跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 62,573 条关于
“muscarinic cholinergic receptors 1”
全部
62,573
临床试验
37,610
药物
7,764
机构
1,390
资讯
15,809
去年
Xanomeline/Trospium (Cobenfy) Approved: A Novel Approach to Schizophrenia Treatment
去年
Schizophrenia Treatment Targeting Cholinergic Receptors Receives FDA Approval
去年
FDA Approves Cobenfy, a Novel Schizophrenia Treatment Targeting Cholinergic Receptors
3个月前
Cholinergic Regulation of Neuroinflammation: Microglia, Immunometabolism, and Therapeutic Frontiers
2年前
FDA Approves Cobenfy, a Novel Schizophrenia Treatment Targeting Cholinergic Receptors
去年
FDA Approves Cobenfy, a Novel Schizophrenia Treatment Targeting Cholinergic Receptors
去年
FDA Approves Cobenfy, a Novel Muscarinic Receptor-Targeting Drug for Schizophrenia
10个月前
Neumora Therapeutics Initiates Phase 1 Trial for Second M4 Muscarinic Receptor Modulator NMRA-898
去年
Xanomeline/Trospium Chloride (COBENFY™) Approved for Schizophrenia Treatment
去年
Neumora Therapeutics Initiates Phase 1 Trial of Novel M4 Receptor Modulator NMRA-861 for Schizophrenia
第 1 页，共 1581 页
上一页
下一页
